Literature DB >> 34992325

Fragmentation dynamics of single agglomerate-to-wall impaction.

A Lowe1, G Singh1, H-K Chan2, A R Masri1, S Cheng3, A Kourmatzis1.   

Abstract

The de-agglomeration characteristics of single agglomerate-wall impaction are examined using high-resolution shadowgraph imaging. Experiments are performed to investigate the effects of constituent particle size (D 50 from 3-7 μ m) and air velocity on the individual size and velocity of de-agglomerated fragments at conditions relevant to dry powder inhalation systems. De-agglomerated fragment area and trajectories were used to differentiate between pseudo-elastic and inelastic collisions during de-agglomeration. Advanced image processing techniques have enabled provision of joint population distributions of fragment area and aspect ratio, which identify a bimodal dispersion of fragments during de-agglomeration. The bimodality is destroyed with increasing air velocity and also generally diminishes with time after impact. The experiment presented forms a platform for the detailed quantitative characterisation of de-agglomeration behaviour and can be useful towards the development and validation of related computational models for pharmaceutical dry powder inhalers.

Entities:  

Keywords:  Dry powder inhalers; de-agglomeration; pharmaceutical powders

Year:  2021        PMID: 34992325      PMCID: PMC8724865          DOI: 10.1016/j.powtec.2020.10.021

Source DB:  PubMed          Journal:  Powder Technol        ISSN: 0032-5910            Impact factor:   5.134


  20 in total

1.  Analysis of the compression mechanics of pharmaceutical agglomerates of different porosity and composition using the Adams and Kawakita equations.

Authors:  F Nicklasson; G Alderborn
Journal:  Pharm Res       Date:  2000-08       Impact factor: 4.200

2.  Deagglomeration of dry powder pharmaceutical aerosols.

Authors:  Austin Voss; Warren H Finlay
Journal:  Int J Pharm       Date:  2002-11-06       Impact factor: 5.875

3.  Review of dry powder inhalers.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1997-06-09       Impact factor: 15.470

4.  Particle aerosolisation and break-up in dry powder inhalers 1: evaluation and modelling of venturi effects for agglomerated systems.

Authors:  William Wong; David F Fletcher; Daniela Traini; Hak-Kim Chan; John Crapper; Paul M Young
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

Review 5.  Numerical Modelling of Agglomeration and Deagglomeration in Dry Powder Inhalers: A Review.

Authors:  Jiecheng Yang; Chuan-Yu Wu; Michael Adams
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

6.  The cohesive-adhesive balances in dry powder inhaler formulations I: Direct quantification by atomic force microscopy.

Authors:  Philippe Begat; David A V Morton; John N Staniforth; Robert Price
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

Review 7.  Dry powder inhalers for pulmonary drug delivery.

Authors:  H W Frijlink; A H De Boer
Journal:  Expert Opin Drug Deliv       Date:  2004-11       Impact factor: 6.648

Review 8.  Dry powder inhaler formulation.

Authors:  Martin J Telko; Anthony J Hickey
Journal:  Respir Care       Date:  2005-09       Impact factor: 2.258

9.  Influence of air flow on the performance of a dry powder inhaler using computational and experimental analyses.

Authors:  Matthew S Coates; Hak-Kim Chan; David F Fletcher; Judy A Raper
Journal:  Pharm Res       Date:  2005-08-24       Impact factor: 4.200

10.  Particle aerosolisation and break-up in dry powder inhalers: evaluation and modelling of the influence of grid structures for agglomerated systems.

Authors:  William Wong; David F Fletcher; Daniela Traini; Hak-Kim Chan; John Crapper; Paul M Young
Journal:  J Pharm Sci       Date:  2011-06-21       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.